astellas pharma

The astellas pharma tag covers an enterprise drug-discovery deployment using NVIDIA’s Boltz-2 NIM and the Tokyo-1 computational foundation. Astellas applies the system to membrane-protein research, presenting results through a browser-based workflow designed for chemists rather than only computational specialists. The reported evaluation selected 10 compounds, all of which showed the expected medicinal effects, while reducing the number of evaluated compounds by more than 90% and shortening the research period by more than 70%. This page focuses on how a pharmaceutical company is applying scientific AI models and production infrastructure to make experimental drug research more efficient and accessible.